0001660549-16-000005.txt : 20160613
0001660549-16-000005.hdr.sgml : 20160613
20160613101936
ACCESSION NUMBER: 0001660549-16-000005
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160613
DATE AS OF CHANGE: 20160613
EFFECTIVENESS DATE: 20160613
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Advantagene, Inc.
CENTRAL INDEX KEY: 0001660549
IRS NUMBER: 522214857
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-261703
FILM NUMBER: 161710120
BUSINESS ADDRESS:
STREET 1: 440 LEXINGTON STREET
CITY: AUBURNDALE
STATE: MA
ZIP: 02466
BUSINESS PHONE: 617-916-5445
MAIL ADDRESS:
STREET 1: 440 LEXINGTON STREET
CITY: AUBURNDALE
STATE: MA
ZIP: 02466
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001660549
Advantagene, Inc.
440 LEXINGTON STREET
AUBURNDALE
MA
MASSACHUSETTS
02466
617-916-5445
DELAWARE
None
None
Corporation
true
Estuardo
Aguilar-Cordova
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Executive Officer
Director
Laura
Aguilar
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Executive Officer
Stephen
C.
Rocamboli
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Executive Officer
Mitchell
Finer
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Director
Udi
Merav
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Director
Fred
Mermelstein
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Director
Glenn
Mattes
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Director
Alan
Smith
c/o 440 Lexington Street
Auburndale
MA
MASSACHUSETTS
02466
Director
Biotechnology
Decline to Disclose
- 06b
true
0001660549-16-000004
2016-05-31
false
true
false
0
National Securities Corporation
7569
National Securities Corporation
7569
410 Park Avenue, 14th Floor
New York
NY
NEW YORK
10022
All States
false
35000000
9957971
25042029
false
191
1005796
0
0
Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering.
false
Advantagene, Inc.
/s/ Stephen C. Rocamboli
Stephen C. Rocamboli
Chief Business Officer
2016-06-13